nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Upper limb oedema—Hydrochlorothiazide—nephrolithiasis	0.148	0.178	CcSEcCtD
Etoricoxib—Coxalgia—Hydrochlorothiazide—nephrolithiasis	0.085	0.102	CcSEcCtD
Etoricoxib—Oral lesion—Hydrochlorothiazide—nephrolithiasis	0.0488	0.0587	CcSEcCtD
Etoricoxib—Oral disorder—Hydrochlorothiazide—nephrolithiasis	0.0281	0.0337	CcSEcCtD
Etoricoxib—Shoulder pain—Hydrochlorothiazide—nephrolithiasis	0.0263	0.0316	CcSEcCtD
Etoricoxib—CYP2C19—urine—nephrolithiasis	0.0203	0.121	CbGeAlD
Etoricoxib—PTGS2—nephron—nephrolithiasis	0.0171	0.102	CbGeAlD
Etoricoxib—CYP1A2—urine—nephrolithiasis	0.0166	0.0986	CbGeAlD
Etoricoxib—CYP2C9—urine—nephrolithiasis	0.0158	0.0936	CbGeAlD
Etoricoxib—CYP2E1—urine—nephrolithiasis	0.0149	0.0887	CbGeAlD
Etoricoxib—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0179	CcSEcCtD
Etoricoxib—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0162	CcSEcCtD
Etoricoxib—Epigastric discomfort—Hydrochlorothiazide—nephrolithiasis	0.0135	0.0162	CcSEcCtD
Etoricoxib—CYP3A4—urine—nephrolithiasis	0.012	0.0713	CbGeAlD
Etoricoxib—CYP2D6—urine—nephrolithiasis	0.0118	0.0702	CbGeAlD
Etoricoxib—MAPK14—renal system—nephrolithiasis	0.0117	0.0695	CbGeAlD
Etoricoxib—Toothache—Hydrochlorothiazide—nephrolithiasis	0.0116	0.014	CcSEcCtD
Etoricoxib—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0139	CcSEcCtD
Etoricoxib—MAPK14—kidney—nephrolithiasis	0.0113	0.0672	CbGeAlD
Etoricoxib—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0127	CcSEcCtD
Etoricoxib—Nephritis interstitial—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0126	CcSEcCtD
Etoricoxib—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0124	CcSEcCtD
Etoricoxib—Heartburn—Hydrochlorothiazide—nephrolithiasis	0.0103	0.0124	CcSEcCtD
Etoricoxib—Tubulointerstitial nephritis—Hydrochlorothiazide—nephrolithiasis	0.00925	0.0111	CcSEcCtD
Etoricoxib—Memory impairment—Hydrochlorothiazide—nephrolithiasis	0.00903	0.0109	CcSEcCtD
Etoricoxib—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.00875	0.0105	CcSEcCtD
Etoricoxib—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00861	0.0104	CcSEcCtD
Etoricoxib—Gastrooesophageal reflux disease—Hydrochlorothiazide—nephrolithiasis	0.00785	0.00943	CcSEcCtD
Etoricoxib—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00764	0.00919	CcSEcCtD
Etoricoxib—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00722	0.00868	CcSEcCtD
Etoricoxib—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00717	0.00862	CcSEcCtD
Etoricoxib—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00696	0.00837	CcSEcCtD
Etoricoxib—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00669	0.00804	CcSEcCtD
Etoricoxib—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00641	0.0077	CcSEcCtD
Etoricoxib—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.00591	0.00711	CcSEcCtD
Etoricoxib—Gastroenteritis—Hydrochlorothiazide—nephrolithiasis	0.0058	0.00698	CcSEcCtD
Etoricoxib—Injury—Hydrochlorothiazide—nephrolithiasis	0.0056	0.00673	CcSEcCtD
Etoricoxib—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00653	CcSEcCtD
Etoricoxib—Visual disturbance—Hydrochlorothiazide—nephrolithiasis	0.00543	0.00653	CcSEcCtD
Etoricoxib—Thirst—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0065	CcSEcCtD
Etoricoxib—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.0054	0.0065	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00619	CcSEcCtD
Etoricoxib—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00619	CcSEcCtD
Etoricoxib—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00482	0.00579	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.0047	0.00565	CcSEcCtD
Etoricoxib—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00559	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00557	CcSEcCtD
Etoricoxib—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00557	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00463	0.00557	CcSEcCtD
Etoricoxib—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00547	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00546	CcSEcCtD
Etoricoxib—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00546	CcSEcCtD
Etoricoxib—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00448	0.00538	CcSEcCtD
Etoricoxib—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00436	0.00524	CcSEcCtD
Etoricoxib—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00521	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00413	0.00497	CcSEcCtD
Etoricoxib—CYP1A2—renal system—nephrolithiasis	0.00406	0.0241	CbGeAlD
Etoricoxib—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00488	CcSEcCtD
Etoricoxib—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00405	0.00487	CcSEcCtD
Etoricoxib—CYP2E1—nephron tubule—nephrolithiasis	0.00402	0.0239	CbGeAlD
Etoricoxib—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00482	CcSEcCtD
Etoricoxib—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00399	0.00479	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00393	0.00473	CcSEcCtD
Etoricoxib—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00391	0.0047	CcSEcCtD
Etoricoxib—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.0039	0.00469	CcSEcCtD
Etoricoxib—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00467	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00389	0.00467	CcSEcCtD
Etoricoxib—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00386	0.00465	CcSEcCtD
Etoricoxib—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00463	CcSEcCtD
Etoricoxib—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00385	0.00463	CcSEcCtD
Etoricoxib—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00378	0.00454	CcSEcCtD
Etoricoxib—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00374	0.0045	CcSEcCtD
Etoricoxib—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00372	0.00447	CcSEcCtD
Etoricoxib—CYP2E1—renal system—nephrolithiasis	0.00365	0.0217	CbGeAlD
Etoricoxib—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00356	0.00428	CcSEcCtD
Etoricoxib—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00354	0.00426	CcSEcCtD
Etoricoxib—CYP2E1—kidney—nephrolithiasis	0.00353	0.021	CbGeAlD
Etoricoxib—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00425	CcSEcCtD
Etoricoxib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00422	CcSEcCtD
Etoricoxib—CYP2E1—cortex of kidney—nephrolithiasis	0.00344	0.0204	CbGeAlD
Etoricoxib—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00412	CcSEcCtD
Etoricoxib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00336	0.00405	CcSEcCtD
Etoricoxib—PTGS2—renal system—nephrolithiasis	0.00336	0.02	CbGeAlD
Etoricoxib—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00332	0.00399	CcSEcCtD
Etoricoxib—Flushing—Hydrochlorothiazide—nephrolithiasis	0.0033	0.00397	CcSEcCtD
Etoricoxib—PTGS2—kidney—nephrolithiasis	0.00325	0.0193	CbGeAlD
Etoricoxib—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00382	CcSEcCtD
Etoricoxib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00378	CcSEcCtD
Etoricoxib—Erythema—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00372	CcSEcCtD
Etoricoxib—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00305	0.00367	CcSEcCtD
Etoricoxib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00303	0.00365	CcSEcCtD
Etoricoxib—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00298	0.00358	CcSEcCtD
Etoricoxib—CYP3A4—renal system—nephrolithiasis	0.00294	0.0175	CbGeAlD
Etoricoxib—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00351	CcSEcCtD
Etoricoxib—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00349	CcSEcCtD
Etoricoxib—CYP2D6—renal system—nephrolithiasis	0.00289	0.0172	CbGeAlD
Etoricoxib—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00344	CcSEcCtD
Etoricoxib—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00285	0.00342	CcSEcCtD
Etoricoxib—CYP3A4—kidney—nephrolithiasis	0.00284	0.0169	CbGeAlD
Etoricoxib—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00283	0.0034	CcSEcCtD
Etoricoxib—CYP2D6—kidney—nephrolithiasis	0.0028	0.0166	CbGeAlD
Etoricoxib—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00274	0.00329	CcSEcCtD
Etoricoxib—Cough—Hydrochlorothiazide—nephrolithiasis	0.0027	0.00325	CcSEcCtD
Etoricoxib—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00317	CcSEcCtD
Etoricoxib—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00264	0.00317	CcSEcCtD
Etoricoxib—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00263	0.00316	CcSEcCtD
Etoricoxib—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00258	0.0031	CcSEcCtD
Etoricoxib—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00255	0.00307	CcSEcCtD
Etoricoxib—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00304	CcSEcCtD
Etoricoxib—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00253	0.00304	CcSEcCtD
Etoricoxib—Shock—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00299	CcSEcCtD
Etoricoxib—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.00248	0.00298	CcSEcCtD
Etoricoxib—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00241	0.0029	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00277	CcSEcCtD
Etoricoxib—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00275	CcSEcCtD
Etoricoxib—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00225	0.00271	CcSEcCtD
Etoricoxib—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00225	0.0027	CcSEcCtD
Etoricoxib—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00223	0.00268	CcSEcCtD
Etoricoxib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.0022	0.00264	CcSEcCtD
Etoricoxib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00218	0.00262	CcSEcCtD
Etoricoxib—Pain—Hydrochlorothiazide—nephrolithiasis	0.00216	0.0026	CcSEcCtD
Etoricoxib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00216	0.0026	CcSEcCtD
Etoricoxib—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00208	0.00251	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00207	0.00249	CcSEcCtD
Etoricoxib—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00201	0.00242	CcSEcCtD
Etoricoxib—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.002	0.0024	CcSEcCtD
Etoricoxib—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00186	0.00224	CcSEcCtD
Etoricoxib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00181	0.00218	CcSEcCtD
Etoricoxib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00215	CcSEcCtD
Etoricoxib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00173	0.00208	CcSEcCtD
Etoricoxib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00167	0.00201	CcSEcCtD
Etoricoxib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00161	0.00193	CcSEcCtD
Etoricoxib—Rash—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00192	CcSEcCtD
Etoricoxib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00159	0.00192	CcSEcCtD
Etoricoxib—Headache—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0019	CcSEcCtD
Etoricoxib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0015	0.00181	CcSEcCtD
